glp-1 agonist adverse effects Your guide to side Glucagon-like Receptor-1 agonists for obesity:

With their ability to control blood sugar levels, GLP-1s have also demonstrated positive impacts on weight loss and reduced cardiovascular risks

There's a risk of gallstones, pancreatitis

Arguin H, Bouchard DR, Labont M, et al

Clinicians need to maintain heightened vigilance on patients premedicated with neuropsychotropic drugs

Gasbjerg LS, Helsted MM, Hartmann B, Sparre-Ulrich AH, Veedfald S, Stensen S, Lanng AR, Bergmann NC, Christensen MB, Vilsboll T, et al

Additionally, GLP-1 agonists suppress glucagon secretion from pancreatic alpha cells, slow gastric emptying, and promote satiety through central nervous system effects, contributing to weight loss in many patients